insights_auto
Mengapa BAVA naik 2,96%?
Pelajari Lebih Lanjutchevron_right
BAVA:CPH
Bavarian Nordic A/S
DKKÂ 236,80
arrow_upward
+2,96%(+6,80) 1 HR
9 Okt, 17.00.00 GMT+2 · DKK
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk BAVA...
Pembukaan
DKKÂ 230,60
Tinggi
DKKÂ 236,80
Rendah
DKKÂ 230,60
Kapitalisasi pasar
18,77Â M
Volume rata-rata
163,97Â rb
Volume
289,90Â rb
Harga tinggi dalam 52 minggu terakhir
DKKÂ 243,70
Harga rendah dalam 52 minggu terakhir
DKKÂ 171,30
Saham beredar
79,27Â jt
Jumlah karyawan
2Â rb
Pembukaan
DKKÂ 230,60
Tinggi
DKKÂ 236,80
Rendah
DKKÂ 230,60
Kapitalisasi pasar
18,77Â M
Volume rata-rata
163,97Â rb
Volume
289,90Â rb
Harga tinggi dalam 52 minggu terakhir
DKKÂ 243,70
Harga rendah dalam 52 minggu terakhir
DKKÂ 171,30
Saham beredar
79,27Â jt
Jumlah karyawan
2Â rb
Artikel berita
Dari sumber web dan partner berita
Pluang
·
23 jam yang lalu
S&P 500 melemah 2000-2008, nilai riil turun sem...
Kompas.com
·
9 jam yang lalu
Wall Street Menguat Ditopang Saham Teknologi, Dow Jones Naik 400 Poin
Limapagi
·
17 jam yang lalu
Wall Street Prediksi S&P 500 Menguat hingga Akhir 2026
Profil
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
Tentang Bavarian Nordic A/S